Impax Laboratories Inc (NASDAQ:IPXL)

46.21
Delayed Data
As of May 22
 +0.75 / +1.65%
Today’s Change
22.12
Today|||52-Week Range
52.10
+45.86%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 45.50, with a high estimate of 58.00 and a low estimate of 27.00. The median estimate represents a -1.54% decrease from the last price of 46.21.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.10
Sales
$145.4M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -38.04%
 
 
 
 
 
 
Growthannually 2.24%
 
 
 
 
 
 

Sales

Growthquarterly 10.79%
 
 
 
 
 
 
Growthannually 33.19%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account